17 alpha-hydroxyprogesterone caproate has been researched along with Fetal Death in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Rubin, R | 1 |
| Berghella, V; Figueroa, D; Guzman, ER; Hankins, GD; Iams, JD; Owen, J; Perez-Delboy, A; Sheffield, JS; Szychowski, JM; Wing, DA | 1 |
| Istwan, NB; Palmer, B; Sibai, BM; Stanziano, GJ | 1 |
| O'Brien, JM | 1 |
| Binkerd, P; Günzel, P; Hendrickx, AG; Korte, R; Leuschner, F; Neumann, BW; Poggel, A; Prahalada, S | 1 |
| Bruen, JA; Hick, JF; Kurland, LT; Noller, KL; O'Fallon, WM; Resseguie, LJ | 1 |
1 review(s) available for 17 alpha-hydroxyprogesterone caproate and Fetal Death
| Article | Year |
|---|---|
The safety of progesterone and 17-hydroxyprogesterone caproate administration for the prevention of preterm birth: an evidence-based assessment.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Spontaneous; Animals; Blood Glucose; Clinical Trials as Topic; Female; Fetal Death; Fetal Development; Hormone Antagonists; Humans; Hydroxyprogesterones; Immunity, Innate; Pregnancy; Pregnancy, Multiple; Premature Birth; Progesterone; Progestins; Receptors, Progesterone; Stillbirth | 2012 |
1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Fetal Death
| Article | Year |
|---|---|
17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Cerclage, Cervical; Cervical Length Measurement; Female; Fetal Death; Humans; Hydroxyprogesterones; Infant, Newborn; Logistic Models; Multivariate Analysis; Perinatal Mortality; Pregnancy; Premature Birth; Progestins; Treatment Outcome; Uterine Cervical Incompetence; Young Adult | 2010 |
4 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Fetal Death
| Article | Year |
|---|---|
Confirmatory Trial for Drug to Prevent Preterm Birth Finds No Benefit, So Why Is It Still Prescribed?
Topics: 17 alpha-Hydroxyprogesterone Caproate; Clinical Trials as Topic; Conflict of Interest; Drug and Narcotic Control; Drug Industry; Female; Fetal Death; Humans; Infant, Newborn; Obstetrics; Perinatal Death; Pregnancy; Premature Birth; Progestins; Research Design; Societies, Medical; Treatment Failure; United States; United States Food and Drug Administration | 2020 |
Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Drug Packaging; Female; Fetal Death; Home Care Services; Humans; Hydroxyprogesterones; Infant Mortality; Infant, Newborn; Pregnancy; Pregnancy Outcome; Premature Birth; Progestins | 2012 |
Embryotoxicity of sex steroidal hormones in nonhuman primates: II. Hydroxyprogesterone caproate, estradiol valerate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Abortion, Veterinary; Animals; Drug Combinations; Estradiol; Female; Fetal Death; Fetal Resorption; Gestational Age; Hydroxyprogesterones; Macaca fascicularis; Macaca mulatta; Maternal-Fetal Exchange; Pregnancy | 1987 |
Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Ethisterone; Female; Fetal Death; Humans; Hydroxyprogesterones; Infant, Newborn; Male; Maternal-Fetal Exchange; Medroxyprogesterone; Minnesota; Norethindrone; Pregnancy; Prenatal Exposure Delayed Effects; Progesterone; Progestins | 1985 |